Cargando…

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter

Cisplatin is one of the most potent chemotherapeutic agents for the treatment of colon cancer. Nevertheless, the unavoidability of the notable toxicity and the development of the acquired resistance severely restricted its clinical application. Aspirin and some other non-steroidal anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Yan, Yue, Chen, Manyu, Luo, Guangyu, Hao, Jiaojiao, Pan, Jinjin, Hu, Sheng, Guo, Ping, Li, Wenyang, Wang, Ruozu, Zuo, Yan, Sun, Yao, Sui, Silei, Yu, Wendan, Pan, Zhe, Zou, Kun, Zheng, Zongheng, Deng, Wuguo, Wu, Xiaojun, Guo, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977689/ https://www.ncbi.nlm.nih.gov/pubmed/31905343 http://dx.doi.org/10.18632/aging.102644

Ejemplares similares

SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression
por: Diao, Chaoliang, et al.
Publicado: (2021)

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
por: Yu, Wendan, et al.
Publicado: (2020)

CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation
por: Liao, Yina, et al.
Publicado: (2020)

Cox1 mutation abrogates need for Cox23 in cytochrome c oxidase biogenesis
por: Dela Cruz, Richard, et al.
Publicado: (2016)

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
por: Li, Zongjuan, et al.
Publicado: (2020)

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance
por: Hao, Jiaojiao, et al.
Publicado: (2023)

Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma
por: Li, Wenbin, et al.
Publicado: (2020)

Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways
por: Yi, Canhui, et al.
Publicado: (2014)

YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC
por: Cui, Yanwei, et al.
Publicado: (2020)

The effects of aspirin plus cisplatin on SGC7901/CDDP cells in vitro
por: DONG, HANZHANG, et al.
Publicado: (2014)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma
por: Harrington, Louise S., et al.
Publicado: (2008)

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2019)

Small interfering RNA-based molecular therapy of cancers
por: Guo, Wei, et al.
Publicado: (2013)

Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance
por: Markosyan, Nune, et al.
Publicado: (2014)

Association of GPIa and COX‐2 gene polymorphism with aspirin resistance
por: Wang, Hui, et al.
Publicado: (2017)

Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor
por: Lieder, Helmut Raphael, et al.
Publicado: (2022)

Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest
por: Koprinarova, Miglena, et al.
Publicado: (2010)

Ku80 cooperates with CBP to promote COX-2 expression and tumor growth
por: Xiao, Yao, et al.
Publicado: (2015)

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
por: Guo, Jianfeng, et al.
Publicado: (2021)

High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

Aspirin Ameliorates Pancreatic Inflammation and Fibrosis by Inhibiting COX-2 Expression in Experimental Chronic Pancreatitis
por: Xu, Xiao-Fan, et al.
Publicado: (2022)

BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits
por: Zhao, Xinrui, et al.
Publicado: (2018)

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
por: Ornelas, Argentina, et al.
Publicado: (2017)

An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
por: Sui, Silei, et al.
Publicado: (2020)

Mycobacterium tuberculosis-Induced Upregulation of the COX-2/mPGES-1 Pathway in Human Macrophages Is Abrogated by Sulfasalazine
por: Wang, Wenfei, et al.
Publicado: (2022)

Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
por: Yu, Zhenlong, et al.
Publicado: (2014)

Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
por: Yu, Zhenlong, et al.
Publicado: (2023)

COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
por: Müller, Norbert
Publicado: (2019)

Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase
por: Long, Qian, et al.
Publicado: (2020)

Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis
por: Tian, Tian, et al.
Publicado: (2020)

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss
por: Crabb, Simon J., et al.
Publicado: (2017)

Expression of COX-1, COX-2, 5-LOX and [Formula: see text] in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease
por: Vorsprach, Monique, et al.
Publicado: (2019)

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G(2)/M cell cycle arrest
por: Sarin, Navin, et al.
Publicado: (2017)

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
por: Crofford, Leslie J
Publicado: (2003)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Upregulation of neurovascular communication through filamin abrogation promotes ectopic periventricular neurogenesis
por: Houlihan, Shauna L, et al.
Publicado: (2016)

Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells
por: Zou, Zhigeng, et al.
Publicado: (2021)

Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
por: Liu, Kaili, et al.
Publicado: (2020)

Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
por: Zhao, Maoyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hb4iqer0qr71h0j0vo19kthpa7